Investments in diagnostics, cancer treatment and services – Docrates Cancer Center published its 2023 annual review
By Lotta Mitro
CEO Ilpo Tolonen comments on the results for 2023: “We are decisively advancing our strategy by providing individualised, innovative and timely world-class cancer diagnostics and treatment to customers who pay for the service themselves or via insurance. We enhanced our services by investing in our facilities, providing new services and advanced customer experiences for our … Continued